ExpreS2ion Biotechnologies - Presentation of Q1 2025 report (Recording)
15 maj, 16:07
15 maj, 16:07
Today, ExpreS2ion Biotechnologies’ CEO, Bent Frandsen, presented the results for the first quarter of 2025, provided further insights into the recent pipeline developments, and shared the latest updates on partnerships aimed at commercializing the company’s technology platform.
Watch the recording here:
https://www.inderes.dk/videos/expres2ion-biotechnologies-presentation-of-q1-2025
ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system.
Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 16:07, 15-06-2025
15 maj, 16:07
Today, ExpreS2ion Biotechnologies’ CEO, Bent Frandsen, presented the results for the first quarter of 2025, provided further insights into the recent pipeline developments, and shared the latest updates on partnerships aimed at commercializing the company’s technology platform.
Watch the recording here:
https://www.inderes.dk/videos/expres2ion-biotechnologies-presentation-of-q1-2025
ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system.
Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 16:07, 15-06-2025
Analys
Investmentbolagens innehav
Analys
Investmentbolagens innehav
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 501,57
Qliro
Igår, 15:22
Analys: Lovande tendenser hos Qliro